Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fetal DNA in maternal plasma: the plot thickens and the placental barrier thins.

Literature DB >> 9529367

Fetal DNA in maternal plasma: the plot thickens and the placental barrier thins.

D W Bianchi.

Abstract

Mesh：

Substances：
DNA

Year: 1998 PMID： 9529367 PMCID： PMC1377047 DOI： 10.1086/301809

Source DB: PubMed Journal: Am J Hum Genet ISSN： 0002-9297 Impact factor: 11.025

× No keyword cloud information.

13 in total

1. Prenatal diagnosis of fetal hemoglobin Lepore-Boston disease on maternal peripheral blood.

Authors: C Camaschella; A Alfarano; E Gottardi; M Travi; P Primignani; F Caligaris Cappio; G Saglio
Journal: Blood Date: 1990-06-01 Impact factor: 22.113

2. Ratio of fetal to maternal DNA is less than 1 in 5000 at different gestational ages in maternal blood.

Authors: D Gänshirt-Ahlert; M Pohlschmidt; A Gal; P Miny; J Horst; W Holzgreve
Journal: Clin Genet Date: 1990-07 Impact factor: 4.438

3. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.

Authors: Y M Lo; M S Tein; T K Lau; C J Haines; T N Leung; P M Poon; J S Wainscoat; P J Johnson; A M Chang; N M Hjelm
Journal: Am J Hum Genet Date: 1998-04 Impact factor: 11.025

4. Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood.

Authors: M C Cheung; J D Goldberg; Y W Kan
Journal: Nat Genet Date: 1996-11 Impact factor: 38.330

5. Rare event selection of fetal nucleated erythrocytes in maternal blood by flow cytometry.

Authors: D E Lewis; W Schober; S Murrell; D Nguyen; J Scott; J Boinoff; J L Simpson; F Z Bischoff; S Elias
Journal: Cytometry Date: 1996-03-01

6. The time of appearance and disappearance of fetal DNA from the maternal circulation.

Authors: M R Thomas; B Tutschek; A Frost; C H Rodeck; N Yazdani; I Craft; R Williamson
Journal: Prenat Diagn Date: 1995-07 Impact factor: 3.050

7. Nucleated erythrocytes in maternal blood: quantity and quality of fetal cells in enriched populations.

Authors: J P Reading; J L Huffman; J C Wu; F T Palmer; G L Harton; M E Sisson; K Keyvanfar; T H Gresinger; W J Cochrane; L A Fallon
Journal: Hum Reprod Date: 1995-09 Impact factor: 6.918

8. Prenatal determination of fetal RhD status by analysis of peripheral blood of rhesus negative mothers.

Authors: Y M Lo; P J Bowell; M Selinger; I Z Mackenzie; P Chamberlain; M D Gillmer; T J Littlewood; K A Fleming; J S Wainscoat
Journal: Lancet Date: 1993-05-01 Impact factor: 79.321

9. The proportion of fetal nucleated red blood cells in maternal blood: estimation by FACS analysis.

Authors: S Sohda; T Arinami; H Hamada; H Nakauchi; H Hamaguchi; T Kubo
Journal: Prenat Diagn Date: 1997-08 Impact factor: 3.050

10. Fetal nucleated cells in maternal peripheral blood: frequency and relationship to gestational age.

Authors: H Hamada; T Arinami; T Kubo; H Hamaguchi; H Iwasaki
Journal: Hum Genet Date: 1993-06 Impact factor: 4.132

13 in total

1. mRNA of placental origin is readily detectable in maternal plasma.

Authors: Enders K O Ng; Nancy B Y Tsui; Tze K Lau; Tse N Leung; Rossa W K Chiu; Nirmal S Panesar; Lydia C W Lit; Kam-Wing Chan; Y M Dennis Lo
Journal: Proc Natl Acad Sci U S A Date: 2003-03-18 Impact factor: 11.205

2. Epigenetic approaches for the detection of fetal DNA in maternal plasma.

Authors: Dana Wy Tsui; Rossa Wk Chiu; Ym Dennis Lo
Journal: Chimerism Date: 2010 Jul-Sep

3. Dynamic changes in fetal microchimerism in maternal peripheral blood mononuclear cells, CD4+ and CD8+ cells in normal pregnancy.

Authors: K M Adams Waldorf; H S Gammill; J Lucas; T M Aydelotte; W M Leisenring; N C Lambert; J L Nelson
Journal: Placenta Date: 2010-05-31 Impact factor: 3.481

Fetal DNA in maternal plasma: the plot thickens and the placental barrier thins.

1. Prenatal diagnosis of fetal hemoglobin Lepore-Boston disease on maternal peripheral blood.

2. Ratio of fetal to maternal DNA is less than 1 in 5000 at different gestational ages in maternal blood.

3. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.

4. Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood.

5. Rare event selection of fetal nucleated erythrocytes in maternal blood by flow cytometry.

6. The time of appearance and disappearance of fetal DNA from the maternal circulation.

7. Nucleated erythrocytes in maternal blood: quantity and quality of fetal cells in enriched populations.

8. Prenatal determination of fetal RhD status by analysis of peripheral blood of rhesus negative mothers.

9. The proportion of fetal nucleated red blood cells in maternal blood: estimation by FACS analysis.

10. Fetal nucleated cells in maternal peripheral blood: frequency and relationship to gestational age.

1. mRNA of placental origin is readily detectable in maternal plasma.

2. Epigenetic approaches for the detection of fetal DNA in maternal plasma.

3. Dynamic changes in fetal microchimerism in maternal peripheral blood mononuclear cells, CD4+ and CD8+ cells in normal pregnancy.

Review 4. Tracking fetal development through molecular analysis of maternal biofluids.

Review 5. Noninvasive prenatal testing: the future is now.

6. Rapid clearance of fetal DNA from maternal plasma.

7. Detection of Y STR markers of male fetal dna in maternal circulation.

8. Profiling circulating microRNAs in maternal serum and plasma.

9. Role of fetal stem cells in maternal tissue regeneration.

10. Cell-free fetal DNA and cell-free total DNA levels in spontaneous abortion with fetal chromosomal aneuploidy.